PROWRITER

  Hair loss treatment through surgery has become very common therapy in patients both male and female specifically androgenic alopecia. FPHL is a clinical ailment that usually occurs in women. The alopecia is called female androgenic alopecia in those women whose level of androgen hormone will become high and if alopecia occurs without an increase in androgen hormones is called FPHL. The therapeutical array of conventional female androgenic alopecia is the dispersed decrease of HF from the front vertical and parietal areas. According to Ludwig, this process is called ‘rarefaction’.  Female androgenetic alopecia is an increasing form of in decreasing HFs in women and usually has three stages: stage 1 which is mild, stage 2 which is moderate, and stage 3 which is chronic. Female androgenetic alopecia occurs in the following situations i.e., obdurate adrenarche syndrome, due to adrenal or tumor in ovaries, post-hysterectomy, and involute alopecia. FPHL can be diagnosed by examining the c